Glycobiology, 2002, Vol. 12, No. 2 119-127
© 2002 Oxford University Press
UDP-GlcNAc concentration is an important factor in the biosynthesis of ß1,6-branched oligosaccharides: regulation based on the kinetic properties of N-acetylglucosaminyltransferase V
3Department of Biochemistry, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
Human ß1,6-N-acetylglucosaminyltransferase V (GnT-V) was expressed by baculovirus-insect cell system, and the purified recombinant enzyme was kinetically characterized. The data obtained were used to establish the kinetic basis of the substrate specificity toward donor nucleotide sugars, and also revealed that Km values for the donors are much higher compared to those of other GlcNAc transferases, the kinetic properties of which have been reported. Because this exceptionally higher Km suggests that GnT-V is physiologically present at far from saturated conditions, it would appear that the production of ß1,6-branched oligosaccharide, which is formed by GnT-V, could be regulated in vivo by the concentration of the donor, UDP-GlcNAc, as well as the expression levels of the enzyme. When B16 melanoma cells, which express high levels of GnT-V, were incubated with GlcNAc, the ß1,6-branched oligosaccharide levels were increased, as judged by a lectin blot analysis, in conjunction with an increase in intracellular UDP-GlcNAc. These findings suggest that the level of UDP-GlcNAc can be a critical factor in the production of ß1,6-branched oligosaccharides, for example, by tumor cells, which have been thought to be closely associated with tumor progression and metastasis.
1 Present address: Laboratory of Molecular Oncology, Osaka Bioscience Institute, 6-2-4 Furuedai, Suita, Osaka 565-0874, Japan
2 To whom correspondence should be addressed
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Okada, H. Ihara, R. Ito, N. Taniguchi, and Y. Ikeda Bidirectional N-acetylglucosamine transfer mediated by {beta}-1,4-N-acetylglucosaminyltransferase III Glycobiology, April 1, 2009; 19(4): 368 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-U. Lee, A. Grigorian, J. Pawling, I-J. Chen, G. Gao, T. Mozaffar, C. McKerlie, and M. Demetriou N-Glycan Processing Deficiency Promotes Spontaneous Inflammatory Demyelination and Neurodegeneration J. Biol. Chem., November 16, 2007; 282(46): 33725 - 33734. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mendelsohn, P. Cheung, L. Berger, E. Partridge, K. Lau, A. Datti, J. Pawling, and J. W. Dennis Complex N-Glycan and Metabolic Control in Tumor Cells Cancer Res., October 15, 2007; 67(20): 9771 - 9780. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cheung, J. Pawling, E. A Partridge, B. Sukhu, M. Grynpas, and J. W Dennis Metabolic homeostasis and tissue renewal are dependent on {beta}1,6GlcNAc-branched N-glycans Glycobiology, August 1, 2007; 17(8): 828 - 837. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Grigorian, S.-U. Lee, W. Tian, I.-J. Chen, G. Gao, R. Mendelsohn, J. W. Dennis, and M. Demetriou Control of T Cell-mediated Autoimmunity by Metabolite Flux to N-Glycan Biosynthesis J. Biol. Chem., July 6, 2007; 282(27): 20027 - 20035. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nakahara, E. Miyoshi, K. Noda, S. Ihara, J. Gu, K. Honke, H. Inohara, T. Kubo, and N. Taniguchi Involvement of oligosaccharide changes in {alpha}5{beta}1 integrin in a cisplatin-resistant human squamous cell carcinoma cell line Mol. Cancer Ther., November 1, 2003; 2(11): 1207 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yada, M. Gotoh, T. Sato, M. Shionyu, M. Go, H. Kaseyama, H. Iwasaki, N. Kikuchi, Y.-D. Kwon, A. Togayachi, et al. Chondroitin Sulfate Synthase-2: MOLECULAR CLONING AND CHARACTERIZATION OF A NOVEL HUMAN GLYCOSYLTRANSFERASE HOMOLOGOUS TO CHONDROITIN SULFATE GLUCURONYLTRANSFERASE, WHICH HAS DUAL ENZYMATIC ACTIVITIES J. Biol. Chem., August 8, 2003; 278(32): 30235 - 30247. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saito, E. Miyoshi, K. Sasai, N. Nakano, H. Eguchi, K. Honke, and N. Taniguchi A Secreted Type of beta 1,6-N-Acetylglucosaminyltransferase V (GnT-V) Induces Tumor Angiogenesis without Mediation of Glycosylation. A NOVEL FUNCTION OF GnT-V DISTINCT FROM THE ORIGINAL GLYCOSYLTRANSFERASE ACTIVITY J. Biol. Chem., May 3, 2002; 277(19): 17002 - 17008. [Abstract] [Full Text] [PDF] |
||||



